SARS-CoV-2 Nucleoprotein Mouse mAb: Selection & Usage Guide
SARS-CoV-2 Nucleoprotein Mouse mAb: Selection & Usage Guide
SARS-CoV-2 Nucleoprotein Mouse mAb is a monoclonal antibody raised in mouse against the nucleoprotein (N protein) of SARS-CoV-2, designed to support sensitive and specific detection of the viral nucleocapsid antigen in a range of research and diagnostic-development applications.
- Product SKU
- Ab350703
- Clone Source / Format
- Mouse monoclonal antibody (mAb)
- Target Antigen
- SARS-CoV-2 Nucleoprotein (N protein / nucleocapsid protein)
- Formulation
- PBS only (no stabilizers or preservatives indicated; absea#KC-445 lot reference)
- Supplier Reference
- absea#KC-445
- Recommended Storage
- Store at −20 °C for long-term; avoid repeated freeze-thaw cycles (standard practice for PBS-formulated mAbs; verify with datasheet)
Product Overview and Target Biology
The SARS-CoV-2 Nucleoprotein Mouse Monoclonal Antibody (Ab350703) targets the nucleocapsid (N) protein of SARS-CoV-2, the causative agent of COVID-19. The N protein is the most abundantly expressed viral protein during infection and plays essential roles in packaging the viral RNA genome, regulating viral transcription, and modulating host immune responses.
Because of its high expression level and relative sequence conservation among betacoronaviruses, the N protein is a primary antigen of choice for diagnostic assays, seroprevalence studies, and basic virological research. A mouse-derived monoclonal antibody offers the consistency, specificity, and reproducibility required for quantitative and semi-quantitative detection workflows.
Catalog SKU: Ab350703 | Lot reference: absea#KC-445 | Formulation: PBS only.
Recommended Applications and Protocol Guidelines
Mouse monoclonal antibodies against the SARS-CoV-2 N protein are broadly applied in the following research contexts. Always validate the antibody in your specific assay system before committing to large-scale experiments.
- Enzyme-Linked Immunosorbent Assay (ELISA): Use as a capture or detection antibody in sandwich ELISA formats to quantify N protein in cell lysates, culture supernatants, or patient-derived samples (research use only). Typical starting dilutions for detection antibodies range from 1:1,000 to 1:5,000; optimize empirically.
- Western Blotting (WB): Denature samples under reducing conditions and probe nitrocellulose or PVDF membranes. The SARS-CoV-2 N protein has an apparent molecular weight of approximately 46–50 kDa; confirm with a positive control lysate.
- Immunofluorescence (IF) / Immunocytochemistry (ICC): Use on fixed and permeabilized cells infected with SARS-CoV-2 or transfected with N-protein expression constructs. Pair with a species-appropriate secondary antibody conjugated to a fluorophore of choice.
- Immunohistochemistry (IHC): Apply to formalin-fixed, paraffin-embedded (FFPE) tissue sections following antigen retrieval. Optimize antigen-retrieval method and antibody concentration for each tissue type.
- Lateral Flow Assay (LFA) development: Mouse mAbs are commonly conjugated to colloidal gold or colored latex beads for rapid antigen-detection strip development.
Note: Specific validated dilutions, buffers, and controls are not confirmed in current source material. Refer to the product datasheet (absea#KC-445) or contact Aladdin Scientific technical support for application-specific recommendations.
Storage, Handling, and Stability
Proper storage and handling are critical to maintaining the activity and specificity of monoclonal antibodies supplied in PBS-only formulations (i.e., without carrier proteins such as BSA or preservatives such as sodium azide).
- Short-term storage (up to 4 weeks): Store at 2–8 °C.
- Long-term storage: Aliquot into single-use volumes and store at −20 °C or below. Avoid repeated freeze-thaw cycles, which can cause aggregation and loss of binding activity.
- Avoid: Exposure to temperatures above 37 °C, direct light (especially for fluorophore-conjugated derivatives), and repeated temperature cycling.
- Working solutions: Prepare fresh dilutions in an appropriate assay buffer (e.g., PBS with 1% BSA for ELISA). Do not store diluted antibody for extended periods.
- Sterile filtration: The PBS-only formulation is typically sterile-filtered (0.2 µm); confirm on the Certificate of Analysis.
All storage recommendations above reflect general best practices for PBS-formulated mouse mAbs. Confirm exact conditions on the product datasheet for Ab350703 / absea#KC-445.
Quality, Specificity, and Cross-Reactivity Considerations
When selecting and qualifying any monoclonal antibody for research use, consider the following quality attributes:
- Specificity: Confirm that the antibody detects SARS-CoV-2 N protein specifically and assess potential cross-reactivity with related coronaviruses (e.g., SARS-CoV-1, MERS-CoV, seasonal coronaviruses HCoV-NL63, HCoV-229E, HCoV-OC43, HCoV-HKU1). Cross-reactivity data should be available on the product datasheet; contact Aladdin Scientific if not listed.
- Lot-to-lot consistency: Request a Certificate of Analysis (CoA) for lot absea#KC-445 to confirm protein concentration, purity, and QC test results.
- Endotoxin levels: For cell-based or in vivo applications, verify endotoxin content (typically <1 EU/mg for research-grade mAbs).
- Isotype: Knowing the mouse IgG isotype (e.g., IgG1, IgG2a) helps select the correct isotype control and secondary antibody for your assay.
- Functional validation: Always include a positive control (recombinant SARS-CoV-2 N protein or N-protein-expressing cell lysate) and a negative control (irrelevant isotype-matched mAb) in every experiment.
Specific isotype, clone name, purity grade, and cross-reactivity data are not confirmed in the current source material. Flag for datasheet review.
Frequently asked questions
What is the formulation of Ab350703 and how does it affect downstream applications?
Ab350703 is supplied in PBS only (no carrier proteins or preservatives; lot reference absea#KC-445). A PBS-only formulation is advantageous for conjugation reactions (e.g., biotin, fluorophore, or colloidal gold labeling) because the absence of BSA eliminates competitive labeling. However, PBS-only antibodies are more susceptible to freeze-thaw damage; always aliquot before freezing and avoid repeated freeze-thaw cycles.
Can this antibody cross-react with other coronaviruses such as SARS-CoV-1 or MERS-CoV?
Cross-reactivity data for Ab350703 with related coronaviruses (SARS-CoV-1, MERS-CoV, seasonal HCoVs) are not confirmed in the current source material. The SARS-CoV-2 N protein shares approximately 90% amino-acid sequence identity with SARS-CoV-1 N protein, so cross-reactivity with SARS-CoV-1 is plausible but must be experimentally verified. Please consult the product datasheet or contact Aladdin Scientific technical support for confirmed cross-reactivity data.
What controls should I include when using this antibody in ELISA or Western blot?
Always include: (1) a positive control consisting of recombinant SARS-CoV-2 N protein at a known concentration or a lysate from cells expressing the N protein; (2) a negative control using an isotype-matched mouse IgG antibody at the same concentration; and (3) a no-primary-antibody control to assess non-specific secondary antibody binding. These controls allow accurate interpretation of band patterns or signal intensities and help identify assay artifacts.
How should I determine the optimal working concentration of Ab350703?
Optimal working concentration must be determined empirically for each application and sample type. A typical approach is to perform a checkerboard titration (for sandwich ELISA) or a serial dilution series (for WB or IF), starting with the ranges suggested in the product datasheet. Begin with a broad range (e.g., 0.1–10 µg/mL) and narrow down based on signal-to-noise ratio and background levels. Contact Aladdin Scientific for application-specific starting recommendations if the datasheet does not specify.
References
- Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733. doi:10.1056/NEJMoa2001017
- Dutta NK, Mazumdar K, Gordy JT. The Nucleocapsid Protein of SARS-CoV-2: A Target for Vaccine Development. J Virol. 2020;94(13):e00647-20. doi:10.1128/JVI.00647-20
- Burbelo PD, Riedo FX, Morishima C, et al. Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019. J Infect Dis. 2020;222(2):206-213. doi:10.1093/infdis/jiaa273
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证(带存储)